DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Urban TJ, Sebro R, Hurowitz EH, et al. Functional genomics of
membrane transporters in human populations. Genome Res,
2006, 16:223–230.
Wang DS, Kusuhara H, Kato Y, et al. Involvement of organic
cation transporter 1 in the lactic acidosis caused by metformin.
Mol Pharmacol, 2003, 63:844–848.
Wang H, LeCluyse EL. Role of orphan nuclear receptors in the
regulation of drug-metabolising enzymes. Clin Pharmacokinet,
2003, 42:1331–1357.
Wang ZJ, Yin OQP, Tomlinson B, Chow MSS. OCT2
polymorphisms and in-vivo renal functional consequence:
studies with metformin and cimetidine. Pharmacogenet
Genom, 2008, 18:637–645.
Werner A, Moore ML, Mantei N, et al. Cloning and expression
of cDNA for a Na/P i
cotransport system of kidney cortex. Proc
Natl Acad Sci USA, 1991, 88:9608–9612.
Wright SH, Dantzler WH. Molecular and cellular physiology of
renal organic cation and anion transport. Physiol Rev, 2004,
84:987–1049.
Xu F, Gainetdinov RR, Wetsel WC, et al. Mice lacking the
norepinephrine transporter are supersensitive to psychostimulants.
Nature Neurosci, 2000, 3:465–471.
Yamasaki Y, Ieiri I, Kusuhara H, et al. Pharmacogenetic
characterization of sulfasalazine disposition based on NAT2
and ABCG2 (BCRP) gene polymorphisms in humans. Clin
Pharmacol Ther, 2008, 84:95–103.
Zelcer N, van de Wetering K, Hillebrand M, et al. Mice lacking
multidrug resistance protein 3 show altered morphine
pharmacokinetics and morphine-6-glucuronide antinociception.
Proc Natl Acad Sci USA, 2005, 102:7274–7279.
Zhang Y, Benet LZ. The gut as a barrier to drug absorption:
Combined role of cytochrome P450 3A and P-glycoprotein.
Clin Pharmacokinet, 2001, 40:159–168.
Zhang W, He YJ, Han CT, et al. Effect of SLCO1B1 genetic
polymorphism on the pharmacokinetics of nateglinide. Br J
Clin Pharmacol, 2006a, 62:567–572.
Zhang S, Lovejoy KS, Shima JE, et al. Organic cation
transporters are determinants of oxaliplatin cytotoxicity.
Cancer Res, 2006b, 66:8847–8857.
Zhang J, Visser F, King KM, et al. The role of nucleoside
transporters in cancer chemotherapy with nucleoside drugs.
Cancer Metastasis Rev, 2007, 26:85–110.
Zhang W, Yu BN, He YJ, et al. Role of BCRP 421C>A
polymorphism on rosuvastatin pharmacokinetics in healthy
Chinese males. Clin Chim Acta, 2006c, 373:99–103.
121
CHAPTER 5
MEMBRANE TRANSPORTERS AND DRUG RESPONSE